Haleon HLN
NYSE HLN
$9.86 -0.01 (-0.05%)
At close: Aug 20, 2026 · 11:02 AM UTC

Haleon (HLN) Shares Outstanding (2021 - 2026)

Haleon's (HLN) quarterly Shares Outstanding (Entity) came in at $4.3 billion in Q2 2026, down 0.75% on a QoQ basis from $4.4 billion in Q4 2025.

Haleon (HLN) Shares Outstanding (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Shares Outstanding (Entity) data on file, last reported at $4.3 billion in Q2 2026.

  • Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $4.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.3 billion (changed N/A YoY) and the FY2025 annual result came in at $4.4 billion, down 1.64% from the prior year.
  • Shares Outstanding (Entity) declined to $4.3 billion in Q2 2026, from $4.4 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $384.8 billion in Q2 2023 to a low of $12389.0 in Q3 2022.
  • A 5-year average of $45.2 billion and a median of $4.4 billion in 2025 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 1883029.39% — and 2024, when it sank 98.84%.
  • Tracing HLN's Shares Outstanding (Entity) over 5 years: stood at $20.4 million in 2022, then soared by 21944.01% to $4.5 billion in 2023, then decreased by 1.09% to $4.5 billion in 2024, then dropped by 1.64% to $4.4 billion in 2025, then decreased by 0.75% to $4.3 billion in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $4.3 billion (Q2 2026), $4.4 billion (Q4 2025), and $4.5 billion (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.31 Bn 39.66 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.65 Bn 29.98 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.18 Bn 19.52 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.82 Bn 17.94 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.70 Bn 15.31 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - 832.44 Mn
10 Alkermes 8.21 Bn 7.55 Bn 397.90 Mn 167.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 8.92 Bn
Dec 31, 2025 8.98 Bn
Dec 31, 2024 9.13 Bn
Jun 30, 2024 9.18 Bn
Dec 31, 2023 9.23 Bn
Jun 30, 2023 9.23 Bn
May 3, 2023 9.24 Bn
Dec 31, 2022 9.24 Bn
Sep 20, 2022 5.60 Mn
Jun 30, 2022 9.24 Bn
Dec 31, 2021 9.24 Bn